WEKO3
アイテム
Immune evasion by cancer stem cells
https://repository.lib.tottori-u.ac.jp/records/7350
https://repository.lib.tottori-u.ac.jp/records/73508289b423-b7af-4df9-8ef9-235499be73c6
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
rt17_20.pdf (1.0 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2021-09-08 | |||||
| タイトル | ||||||
| タイトル | Immune evasion by cancer stem cells | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題 | Cancer stem cells | |||||
| キーワード | ||||||
| 主題 | Immune evasion | |||||
| キーワード | ||||||
| 主題 | T cells | |||||
| キーワード | ||||||
| 主題 | NK cells | |||||
| キーワード | ||||||
| 主題 | Immune checkpoints | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | Cancer stem cells | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | Immune evasion | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | T cells | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | NK cells | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題 | Immune checkpoints | |||||
| 資源タイプ | ||||||
| 資源タイプ | journal article | |||||
| 著者 |
土谷, 博之
× 土谷, 博之× 汐田, 剛史 |
|||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Medical Genetics and Regenerative Medicine, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University | |||||
| 著者所属（英） | ||||||
| 言語 | en | |||||
| 値 | Division of Medical Genetics and Regenerative Medicine, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University | |||||
| 抄録 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Tumor immunity represents a new avenue for cancer therapy. Immune checkpoint inhibitors have successfully improved outcomes in several tumor types. In addition, currently, immune cell-based therapy is also attracting significant attention. However, the clinical efficacy of these treatments requires further improvement. The mechanisms through which cancer cells escape the immune response must be identified and clarified. Cancer stem cells (CSCs) play a central role in multiple aspects of malignant tumors. CSCs can initiate tumors in partially immunocompromised mice, whereas non-CSCs fail to form tumors, suggesting that tumor initiation is a definitive function of CSCs. However, the fact that non-CSCs also initiate tumors in more highly immunocompromised mice suggests that the immune evasion property may be a more fundamental feature of CSCs rather than a tumor-initiating property. In this review, we summarize studies that have elucidated how CSCs evade tumor immunity and create an immunosuppressive milieu with a focus on CSC-specific characteristics and functions. These profound mechanisms provide important clues for the development of novel tumor immunotherapies. | |||||
| 書誌情報 |
Regenerative Therapy en : Regenerative Therapy 巻 17, p. 20-33, 発行日 2021-06-30 |
|||||
| 出版者 | ||||||
| 出版者 | Elsevier B.V. | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 23523204 | |||||
| DOI | ||||||
| 関連タイプ | isIdenticalTo | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1016/j.reth.2021.02.006 | |||||
| 権利 | ||||||
| 権利情報 | ©2021, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | |||||
| 情報源 | ||||||
| 関連名称 | Tsuchiya, Hiroyuki. Shiota, Goshi. Immune evasion by cancer stem cells. Regenerative Therapy. 17. 20-33. doi:10.1016/j.reth.2021.02.006 | |||||
| 関連サイト | ||||||
| 識別子タイプ | URI | |||||
| 関連識別子 | https://www.sciencedirect.com/science/article/pii/S2352320421000134 | |||||
| 関連名称 | https://www.sciencedirect.com/science/article/pii/S2352320421000134 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
